These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 30102618)

  • 21. Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
    Ebina K; Hashimoto M; Yamamoto W; Ohnishi A; Kabata D; Hirano T; Hara R; Katayama M; Yoshida S; Nagai K; Son Y; Amuro H; Akashi K; Fujimura T; Hirao M; Yamamoto K; Shintani A; Kumanogoh A; Yoshikawa H
    PLoS One; 2018; 13(3):e0194130. PubMed ID: 29543846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
    Fox GB; Esbenshade TA; Pan JB; Radek RJ; Krueger KM; Yao BB; Browman KE; Buckley MJ; Ballard ME; Komater VA; Miner H; Zhang M; Faghih R; Rueter LE; Bitner RS; Drescher KU; Wetter J; Marsh K; Lemaire M; Porsolt RD; Bennani YL; Sullivan JP; Cowart MD; Decker MW; Hancock AA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graded full-thickness anterior blepharotomy for upper eyelid retraction.
    Elner VM; Hassan AS; Frueh BR
    Trans Am Ophthalmol Soc; 2003; 101():67-73; discussion 73-5. PubMed ID: 14971565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
    Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization.
    Radek RJ; Robb HM; Stevens KE; Gopalakrishnan M; Bitner RS
    J Pharmacol Exp Ther; 2012 Dec; 343(3):736-45. PubMed ID: 22988063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histopathology of 8 corneal buttons after penetrating keratoplasty in silicone oil-associated keratopathy].
    Sekundo W; Hesse L; Schmidt J; Kroll P
    Klin Monbl Augenheilkd; 2001 Jun; 218(6):424-8. PubMed ID: 11488008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging antibody-drug conjugates for treating lymphoid malignancies.
    Wolska-Washer A; Robak P; Smolewski P; Robak T
    Expert Opin Emerg Drugs; 2017 Sep; 22(3):259-273. PubMed ID: 28792782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity of a monoclonal F(ab')2:ricin A conjugate for retinoblastoma in vitro.
    Merriam JC; Lyon HS; Char DH
    Cancer Res; 1984 Aug; 44(8):3178-83. PubMed ID: 6744258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic effects of an anti-angiogenic thrombospondin-1 mimetic peptide, ABT-898, on female mouse reproductive outcomes.
    Edwards AK; Olariu I; Nakamura DS; Ahn SH; Tayade C
    Reprod Biol Endocrinol; 2016 Sep; 14(1):56. PubMed ID: 27604347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of ABT-594 in subjects with diabetic peripheral neuropathic pain.
    Dutta S; Awni W
    J Clin Pharm Ther; 2012 Aug; 37(4):475-80. PubMed ID: 22145610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro metabolism of 2-acetylbenzothiophene: relevance to zileuton hepatotoxicity.
    Joshi EM; Heasley BH; Chordia MD; Macdonald TL
    Chem Res Toxicol; 2004 Feb; 17(2):137-43. PubMed ID: 14967000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Male and female fertility assessment in the cynomolgus monkey following administration of ABT-874, a human Anti-IL-12/23p40 monoclonal antibody.
    Enright BP; Tornesi B; Weinbauer GF; Blaich G
    Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):421-30. PubMed ID: 23213064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia.
    Liu SK; Coackley C; Krause M; Jalali F; Chan N; Bristow RG
    Radiother Oncol; 2008 Aug; 88(2):258-68. PubMed ID: 18456354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial.
    Kimball AB; Gordon KB; Langley RG; Menter A; Chartash EK; Valdes J;
    Arch Dermatol; 2008 Feb; 144(2):200-7. PubMed ID: 18283176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells.
    Allaman-Pillet N; Oberson A; Munier F; Schorderet DF
    Ophthalmic Genet; 2013; 34(1-2):1-13. PubMed ID: 21955141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The origin of keratopathy in chronic allergic eye disease: a histopathological study.
    Bacon AS; Tuft SJ; Metz DM; McGill JI; Buckley RJ; Baddeley S; Lightman SL
    Eye (Lond); 1993; 7 ( Pt 3 Suppl )():21-5. PubMed ID: 8253220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.